Educating physicians about ventilation-perfusion scanning as an alternative to CT for the diagnosis of pulmonary embolisms led to a 23 percent decrease in patient exposure, according to a study ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance to 4DMedical’s non-contrast, computed tomography (CT)-based ventilation-perfusion imaging technology, CT:VQ, for respiratory ...

4DMedical Limited has unveiled its innovative CT:VQ technology at RSNA 2024, offering a revolutionary alternative to traditional Nuclear VQ scans. This new imaging solution promises faster, safer, and ...

US FDA assent for 4D Medical’s CT VQ ventilation perfusion device described by the company as a “transformational milestone”. It all started in August when the lung scanning innovator inked a deal ...

Hi, everyone. Thank you so much for joining us today and for your interest in 4DMedical and today's investor presentation. Of course, the key focus of today's presentation is going to be CT:VQ post ...

Educating physicians about ventilation-perfusion scanning (VQ) as an alternative to CT for the diagnosis of pulmonary embolisms led to a 23% decrease in patient exposure, according to a study ...

It all started in August when the lung scanning innovator inked a deal with the giant ASX-listed Pro Medicus, involving a $10 million loan and the hint of other liaisons to come. On September 1, 4D ...

4DMedical Ltd (AU:4DX) has released an update. Don't Miss our Black Friday Offers: 4DMedical Limited has unveiled its innovative CT:VQ technology at RSNA 2024, offering a revolutionary alternative to ...

You make your own luck – and 4D Medical (ASX:4DX) has enjoyed that commodity in shovel-loads over the last month. It all started in August when the lung scanning innovator inked a deal with the giant ...